BLUEPRINT MEDICINES CORP

NASDAQ: BPMC (Blueprint Medicines Corporation)

Kemas kini terakhir: 16 Apr, 5:43PM

82.11

0.66 (0.81%)

  • 1H 0.81%
  • 5H -2.46%
  • 1B -4.46%
  • 6B -9.47%
  • Tahun Ke Tarikh -5.84%
  • 1T -13.44%
  • 5T 43.67%
Penutupan Terdahulu 81.45
Buka 81.05
Jumlah Dagangan 732,483
Purata Dagangan (3B) 1,081,683
Modal Pasaran 5,247,321,600
Harga / Jualan (P/S) 10.06
Harga / Buku (P/B) 17.43
Julat 52 Minggu
73.04 (-11%) — 121.90 (48%)
Tarikh Pendapatan 30 Apr 2025 - 5 May 2025
Margin Keuntungan -13.19%
Margin Operasi (TTM) -28.15%
EPS Cair (TTM) -1.07
Pertumbuhan Hasil Suku Tahunan (YOY) 103.40%
Jumlah Hutang/Ekuiti (D/E MRQ) 242.51%
Nisbah Semasa (MRQ) 2.85
Aliran Tunai Operasi (OCF TTM) -192.59 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -76.03 M
Pulangan Atas Aset (ROA TTM) -11.89%
Pulangan Atas Ekuiti (ROE TTM) -31.26%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Biotechnology (US) Bercampur Bercampur
Biotechnology (Global) Bercampur Bercampur
Stok Blueprint Medicines Corporation Bercampur Menaik

AISkor Stockmoo

2.9
Konsensus Penganalisis 5.0
Aktiviti Orang Dalam NA
Volatiliti Harga 4.5
Purata Bergerak Teknikal 0.0
Osilator Teknikal 2.0
Purata 2.88

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
BPMC 5 B - - 17.43
EXEL 11 B - 22.24 4.73
CORT 8 B - 58.44 11.43
TGTX 6 B - 275.53 26.86
ADMA 5 B - 26.90 15.26
NUVL 5 B - - 5.09

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
Sektor Healthcare
Industri Biotechnology
Gaya Pelaburan Small Growth
% Dimiliki oleh Orang Dalam 0.87%
% Dimiliki oleh Institusi 106.72%
138.20138.20115.10115.1092.0092.0068.9068.9045.8045.80Harga Sasaran MedianQ2 '20Q2 '20Q3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25
Julat 52 Minggu
73.04 (-11%) — 121.90 (48%)
Julat Harga Sasaran
100.00 (21%) — 150.00 (82%)
Tinggi 150.00 (Scotiabank, 82.68%) Beli
Median 129.00 (57.11%)
Rendah 100.00 (Morgan Stanley, 21.79%) Pegang
Purata 128.56 (56.57%)
Jumlah 8 Beli, 1 Pegang
Harga Purata @ Panggilan 92.15
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Needham 28 Apr 2025 130.00 (58.32%) Beli 88.51
08 Apr 2025 133.00 (61.98%) Beli 79.22
Wedbush 16 Apr 2025 128.00 (55.89%) Beli 82.11
Morgan Stanley 20 Mar 2025 100.00 (21.79%) Pegang 88.47
Jefferies 17 Mar 2025 135.00 (64.41%) Beli 92.14
Scotiabank 07 Mar 2025 150.00 (82.68%) Beli 87.12
Citizens Capital Markets 03 Mar 2025 125.00 (52.23%) Beli 89.75
HC Wainwright & Co. 14 Feb 2025 135.00 (64.41%) Beli 93.94
JMP Securities 14 Feb 2025 125.00 (52.23%) Beli 93.94
JP Morgan 04 Feb 2025 129.00 (57.11%) Beli 113.40

Tiada data dalam julat masa ini.

90.2490.2486.0386.0381.8281.8277.6177.6173.4073.40Apr 16Apr 16Apr 17Apr 17Apr 21Apr 21Apr 22Apr 22Apr 23Apr 23Apr 24Apr 24Apr 25Apr 25Apr 28Apr 28

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.0000.000-1.000-1.000-2.000-2.000-3.000-3.000-4.000-4.000MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda